This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

We invite people living with diabetes to join our United Through Diabetes event happening on World Diabetes Day!

Join our World Diabetes Day event?

AZ Banner

This independent webinar series has been funded by AstraZeneca. AstraZeneca has had no editorial input into, or control over the content. Marketing and organisational support by Diabetes Professional Care and MDBriefCase.
For healthcare professionals only.

We are excited to bring you a series of 2 CPD accredited webinars designed to help Healthcare Professionals (HCPs) better manage and prevent Heart Failure in Type 2 Diabetes. This series includes learning resources to complement each webinar: an expert video and 2 podcasts will be made available. Please see the full details below for each of the training webinars.

Register for your free place

 

This webinar series also includes an expert video and 2 podcasts:

  • Expert Video: Strategies for managing at-risk patients with limited access
  • Podcast 1: Class or Drug Effect? – Translating the SGLT2i Evidence 
  • Podcast 2: Demystifying the Cardiovascular Evidence with Antihyperglycaemic Agents

 

Webinar #1 – Managing Heart Failure in your patient with diabetes

Mon 7 Dec- 7pm to 8pm

Any delay in the initiation of recommended treatment can have significant impact on patient outcomes. This session will explore the relationship between HF and diabetes. It will review the management of HF and the current evidence supporting the potential role of SGLT2 inhibitors in improving HF outcomes. Drs. David Strain, Marc Evans, Naresh Kanumilli, and Jim Moore will discuss how the new SGLT2 inhibitor evidence is transforming the type 2 diabetes management algorithms.

Speakers: Dr David Strain Clinical Senior Lecturer, Dr Marc Evans Consultant Diabetologist, Dr Naresh Kanumilli Community Diabetes Consultant and Dr Jim Moore GPwSI Cardiology

Learning Objectives

  • Review the prevalence and consequences of heart failure in type 2 diabetes
  • Manage a patient with diabetes and heart failure according to the current guidelines
  • Apply the latest evidence and guideline recommendations on antihyperglycemic selection to patients with or at risk of heart failure seen in practice

 

Register for your free place

Webinar #2 – Managing CV and HF risk in type 2 diabetes: Beyond glycaemic control 

Mon 14 Dec - 7pm to 8pm 

Although the hyperglycaemia is commonly the focus in diabetes management, cardiovascular disease complications are the primary cause of death of people with diabetes. Increasing evidence has provided healthcare professionals with options to reduce the risk of cardiovascular disease in type 2 diabetes. This 30-minute session will explore the management strategies to improve glycaemic control and reduce cardiovascular risk.

Speakers: Dr Marc Evans Consultant Diabetologist, Dr Naresh Kanumilli Community Diabetes Consultant, Dr Jim Moore GPwSI Cardiology and Dr. Gethin Ellis Consultant in Cardiology 

Learning Objectives

  • Determine the short-term and long-term cardiovascular risk in a patient with type 2 diabetes
  • Review the strategies that have been shown to be effective for primary prevention of cardiovascular disease in type 2 diabetes
  • Discuss strategies to reduce cardiovascular risk and diabetes during times of limited resources

 

Register for your free place

Extra content 

Expert Video 

Strategies for managing at-risk patients with limited access

Heart failure is a common complication in patients with type 2 diabetes. This session will review the incidence and strategies to identify and prevent heart failure. The treatment of heart failure in diabetes will be reviewed. This will include new evidence and guideline recommendations for the management of heart failure in type 2 diabetes.

Podcast 1

Class or Drug Effect? – Translating the SGLT2i Evidence 

There have been a significant number of trials published on SGLT2 inhibitors in the last several years. A common question from healthcare professionals is if the benefits of these agents are drug-specific or a class effect. Professor John Wilding will provide healthcare professionals with a quick update on the similarities and differences between the SGLT2 inhibitors.

Podcast 1

Demystifying the Cardiovascular Evidence with Antihyperglycaemic Agents

The Food and Drug Administration (FDA) in the United States required all new antihyperglycaemic agents to undergo cardiovascular outcome trials prior to approval. This has led to a large number of cardiovascular outcome trials being published. Each of these trials had unique patient criteria and different outcomes. Professor John Wilding and Dr. Naresh Kanumilli will provide healthcare professionals with a quick update on these key trials and how it can impact type 2 diabetes management.

Speakers

Dr David Strain

Clinical Senior Lecturer Diabetes and Vascular Research Centre

Dr David Strain

Dr Marc Evans

Consultant Diabetologist, special interest in health economics, University Hospital Llandough, Cardiff

Marc Evans

 

Dr Naresh Kanumilli

GP with a Special Interest in Diabetes and Cardiology, Manchester

Naresh

Dr Jim Moore 

GPwSI Cardiology, President Primary Care Cardiology Society

Jim Moor

Dr. Gethin Ellis

Consultant in Cardiology and General Medicine at the Royal Glamorgan Hospital

Dr. Gethin Ellis

 

 

AstraZeneca Logo

Twitter

Sponsors

Diamond Sponsor

  • AstraZeneca

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Abbott

 

Gold Sponsor

  • GlucoRX

 

Gold Sponsor

  • Roche

 

Gold Sponsor

  • Insulet

 

Gold Sponsor

  • Lilly

 

Gold Sponsor

  • Napp Logo

 

Silver Sponsor

  • Sanofi

 

Silver Sponsor

  • CDEP

 

Silver Sponsor

  • glooko

 

Silver Sponsor

  • Aga Matrix

 

Silver Sponsor

  • Duet

 

Silver & Registration Sponsor

  • Diabetes Research & Wellness Foundation

 

Partners

Event Partner

  • NHS

Event Partner

  • ABCD

Event Partner

  • Diabetes Times

Event Partner

  • Trend

Event Partner

  • UKPCA

Media Partner

  • Caring Uk

Media Partner

  • Care Hub

Media Partner

  • Lifestyle Hub

Media Partner

  • Hospital Hub

Media Partner

  • Hub News

Media Partner

  • Practical Diabetes

Media Partner

  • Prescriber